{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:53Z","timestamp":1792740533013,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2009.12.050","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T05:13:55Z","timestamp":1262754835000},"page":"2231-2235","source":"Crossref","is-referenced-by-count":170,"title":["Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1\u20134-year-old Israeli children"],"prefix":"10.1016","volume":"28","author":[{"given":"Justen H.","family":"Passwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonit","family":"Banet-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Ramon-Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Farzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Lerner-Geva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Even-Nir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Yerushalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiayung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Shiloach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (10)","key":"10.1016\/j.vaccine.2009.12.050_bib1","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1086\/386326","article-title":"Laboratory-confirmed shigellosis in the United States, 1989\u20132002: epidemiologic trends and patterns","volume":"38","author":"Gupta","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.050_bib2","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.12.050_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM193612242152602","article-title":"The trend of prevention therapy and epidemiology of dysentery since the discovery of its causative organism","volume":"215","author":"Shiga","year":"1936","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.050_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JCM.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.12.050_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.12.050_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.12.050_bib7","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/IAI.59.12.4450-4458.1991","article-title":"Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid","volume":"59","author":"Chu","year":"1991","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.12.050_bib8","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/IAI.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","volume":"61","author":"Taylor","year":"1993","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.12.050_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/314759","article-title":"Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children","volume":"179","author":"Ashkenazi","year":"1999","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.12.050_bib10","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/IAI.64.10.4074-4077.1996","article-title":"Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers","volume":"64","author":"Cohen","year":"1996","journal-title":"Infect Immun"},{"issue":"January (9046)","key":"10.1016\/j.vaccine.2009.12.050_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.12.050_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.inf.0000078156.03697.a5","article-title":"Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children","volume":"22","author":"Passwell","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.12.050_bib13","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide\u2013protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.12.050_bib14","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/IAI.67.10.5526-5529.1999","article-title":"Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide\u2013protein conjugates in mice","volume":"67","author":"Pavliakova","year":"1999","journal-title":"Infect Immun"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2009.12.050_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1432-1033.1984.tb07993.x","article-title":"The Shigella flexneri O-antigenic polysaccharide chain. Nature of the biological repeating unit","volume":"139","author":"Carlin","year":"1984","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2009.12.050_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0008-6215(00)83665-4","article-title":"Structural studies of the O-specific side-chains of the Shigella sonnei Phase I lipopolysaccharide","volume":"78","author":"Kenne","year":"1980","journal-title":"Carbohydr Res"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2009.12.050_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-1033.1978.tb20963.x","article-title":"Structural studies of Shigella flexneri O-antigens","volume":"91","author":"Kenne","year":"1978","journal-title":"Eur J Biochem"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.12.050_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/164.3.533","article-title":"Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei","volume":"164","author":"Formal","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.12.050_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.24.4.273","article-title":"Influenzal meningitis: the relation of age incidence to the bactericidalo power of blood against the causal organism","volume":"24","author":"Fothergill LaW","year":"1933","journal-title":"J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.12.050_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.12.050_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00006454-199510000-00008","article-title":"Shigella lipopolysaccharide antibodies in pediatric populations","volume":"14","author":"Passwell","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2009.12.050_bib22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.12.050_bib23","unstructured":"Thiem VD, Lin FY Cahn DG, Schneerson R, Robbins JB, Szu, S. Vi-rEPA conjugate vaccine is safe and immunogenic in infants and compatible with routine immunization; in preparation."},{"key":"10.1016\/j.vaccine.2009.12.050_bib24","unstructured":"Cohen D, Bassal R, Valinski L, Vasilev V, Green MS for the Shigella Surveillance Network. Cyclic Occurrence of Epidemics of Shigella sonnei Shigellosis in Israel at Vaccines for Enteric Diseases, Malaga, 9\u201311 September 2009."},{"issue":"May (19)","key":"10.1016\/j.vaccine.2009.12.050_bib25","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1073\/pnas.0900891106","article-title":"Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates","volume":"106","author":"Robbins","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.12.050_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-1033.1979.tb13190.x","article-title":"Somatic antigens of Shigella, the structure of the specific polysaccharide of Shigella newcastle (Sh. flexneri type 6) lipopolysaccharide","volume":"98","author":"Dmitriev","year":"1979","journal-title":"Eur J Biochem"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.12.050_bib27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2009.12.050_bib28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0264-410X(96)00006-0","article-title":"Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection","volume":"14","author":"Van De Verg","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.050_bib29","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.12.050_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-1119(97)00143-1","article-title":"Molecular characterization of the genes involved in O-antigen modification, attachment, integration and excision in Shigella flexneri bacteriophage SfV","volume":"195","author":"Huan","year":"1997","journal-title":"Gene"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2009.12.050_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1574-6976.2008.00114.x","article-title":"Structure and genetics of Shigella O antigens","volume":"32","author":"Liu","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.12.050_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/MMBR.41.3.667-710.1977","article-title":"Serology, chemistry, and genetics of O and K antigens of Escherichia coli","volume":"41","author":"Orskov","year":"1977","journal-title":"Bacteriol Rev"},{"issue":"Febraury (4)","key":"10.1016\/j.vaccine.2009.12.050_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/499821","article-title":"Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2\u20135-year-old children","volume":"193","author":"Ahmed","year":"2006","journal-title":"J Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2019.07.065","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T07:03:30Z","timestamp":1685343810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09019604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X09019604"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}